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The primary goal of this study was to characterize the response of chondrocyte-seeded agarose constructs
to varying concentrations of several key nutrients in a chondrogenic medium, within the overall context of
optimizing the key nutrients and the placement of nutrient channels for successful growth of cartilage
tissue constructs large enough to be clinically relevant in the treatment of osteoarthritis (OA). To this end,
chondrocyte–agarose constructs (ø4 · 2.34 mm, 30 · 106 cells/mL) were subjected to varying supplementation
levels of insulin (0· to 30· relative to standard supplementation), transferrin (0· to 30·), selenous acid (0· to
10·), ascorbate (0· to 30· ), and glucose (0· to 3·). The quality of resulting engineered tissue constructs
was evaluated by their compressive modulus (E-Y), tensile modulus (E+Y), hydraulic permeability (k), and content
of sulfated glycosaminoglycans (sGAG) and collagen (COL); DNA content was also quantified. Three control
groups from two separate castings of constructs (1· concentrations of all medium constituents) were used. After
42 days of culture, values in each of these controls were, respectively, E-Y= 518– 78, 401– 113, 236– 67 kPa;
E+Y = 1420– 430, 1140– 490, 1240– 280 kPa; k= 2.3– 0.8· 10- 3, 5.4– 7.0· 10- 3, 3.3– 1.3· 10- 3 mm4/N$s; sGAG=
7.8– 0.3, 6.3– 0.4, 4.1– 0.5%/ww; COL= 1.3– 0.2, 1.1– 0.3, 1.4– 0.4%/ww; and DNA= 11.5– 2.2, 12.1– 0.6,
5.2– 2.8mg/disk. The presence of insulin and ascorbate was essential, but their concentrations may drop as low as
0.3· without detrimental effects on any of the measured properties; excessive supplementation of ascorbate (up
to 30·) was detrimental to E-Y, and 30· insulin was detrimental to both E+Y and E-Y. The presence of glucose was
similarly essential, and matrix elaboration was significantly dependent on its concentration ( p < 10- 6), with loss
of functional properties, composition, and cellularity observed at £0.3· ; excessive glucose supplementation (up
to 3· ) showed no detrimental effects. In contrast, transferrin and selenous acid had no influence on matrix
elaboration. These findings suggest that adequate distributions of insulin, ascorbate, and glucose, but not nec-
essarily of transferrin and selenous acid, must be ensured within large engineered cartilage constructs to produce
a viable substitute for joint tissue lost due to OA.
Introduction
Osteoarthritis (OA) is a pathological condition char-acterized by the breakdown of articular cartilage, re-
sulting in pain, inflammation, and impaired joint mobility.
Although currently no treatments for OA exist that restore
the native joint surface, cartilage tissue engineering is a
promising approach for replenishing lost native tissue with
de novo tissue produced by culturing cells under controlled
conditions within a suitable 3D scaffold. The culture of
chondrocyte-seeded agarose constructs containing 30 · 106
cells/mL in a chemically defined medium under transient
supplementation of human recombinant TGF-b3 has been
shown to reproduce native levels of compressive Young’s
modulus (E-Y) and sulfated glycosaminoglycan (sGAG)
content.2,3 This cell-seeding density is on the same order of
magnitude as the native cell density in adult bovine articular
cartilage (50–150 · 106 cells/mL).4
A major challenge in cartilage tissue engineering is the
ability to make sufficiently large constructs for adequate re-
pair of cartilage defects. Current strategies employ smaller
constructs (*20 mm2); however, OA generally does not
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become symptomatic until the defects reach ‡ 5 cm2, and
therefore small constructs may not ultimately be clinically
relevant for treatment of OA.5,6 As the construct size in-
creases, inhomogeneous tissue properties tend to develop, as
consumption by cells on the periphery results in poor nu-
trient availability toward the construct center.7–10 Various
techniques have been developed to overcome transport lim-
itations such as direct perfusion,11–13 dynamic loading,14–16
and the introduction of nutrient channels.7,17 A major goal of
our research is to implement computational models to opti-
mize the placement of channels for successful growth of
large constructs. This technique necessitates an understand-
ing of which nutrients are critical for tissue growth.
Agarose gels are often employed in cartilage tissue engi-
neering applications, as agarose is known to stabilize the
chondrocyte phenotype in vitro.18–20 Further, proteoglycans
produced by chondrocytes in agarose have been shown to be
most similar to those of native cartilage as compared to
proteoglycans produced in fibrin, alginate, and PGA scaf-
folds.21 Chondrocyte-seeded agarose constructs have also
performed well in an in vivo canine model, wherein the
constructs exhibited excellent integration with the host tis-
sue,22 as well as in phase II clinical trials for autologous
chondrocyte implantation.23 A phase III clinical trial evalu-
ating their efficacy is currently underway in France.24
As an alternative to the serum-based medium, which
contains a complex profile of nutrients and growth factors
that may vary batch to batch, many tissue engineering ex-
periments employ a chemically defined medium, consisting
of insulin-transferrin-selenium (ITS) additives. Insulin is re-
quired for cellular metabolism of glucose and is thus neces-
sary for cell culture.25 Transferrin is an essential protein that
is known to transport iron into cells, where iron plays a role
in the hydroxylation of proline during collagen synthesis,26,27
and selenium is an essential trace element that boosts the
activity of glutathione peroxidases in shielding cells from
oxidative stress.28 ITS-supplemented media have been
shown to viably support and promote matrix deposition
within chondrocyte-seeded agarose constructs.29,30 The ef-
fects of relative concentrations of ITS on cell proliferation
have been investigated in 2D monolayer culture of rat neu-
roblastoma cells31 and HeLa cells, but the specific effects of
ITS concentrations on the functional properties of engineered
cartilage have not been characterized.
Ascorbate is a requisite cofactor in the production of col-
lagen II by chondrocytes32 and has also been observed to
influence sGAG production,33 and thus is an essential me-
dium supplement for cartilage tissue engineering. Ascorbate
levels have been modulated over narrow ranges in short-
term pellet culture,34 and comparisons have been made be-
tween chondrocyte-seeded agarose constructs that have been
cultured in the presence or absence of ascorbate,33,35 yet the
effects of its concentration over a broad range on tissue-en-
gineered constructs remain to be uncovered.
Due to the avascular nature of mature cartilage and its
resulting low oxygen tension, chondrocytes rely primarily
upon glycolysis and lactic acid fermentation to generate
ATP. Further, glucose is used by chondrocytes to form
building blocks in the synthesis of sGAG.36 The chon-
drocytes require adequate glucose concentrations.37,38 Both
chondrocyte density and metabolic consumption shape the
gradient of glucose concentration throughout the depth of
articular cartilage,39 and computational models predict that
glucose gradients are also present in engineered cartilage.40,41
Therefore, it is important to also investigate the influences of
various levels of glucose in our current culture system.
In this study, we characterized the response of chondrocyte-
seeded agarose constructs to varying concentrations of several
key nutrients in a chondrogenic medium (CM), to determine
the relative importance of CM supplements in the growth of
the engineered cartilage.1 This aim was achieved by sub-
jecting chondrocyte–agarose constructs to varying supple-
mentation levels of the three ITS constituents as well as
ascorbate and glucose. The quality of the resulting en-
gineered tissue constructs was evaluated by their mechanical
properties and their content of the major cartilage matrix
constituents, and the effects of nutrient levels on construct
cellularity were examined.
Materials and Methods
Media were prepared, in which the concentrations of each
of the nutrients of interest were individually modulated over
a broad range for 6 weeks of cultivation time. Constructs
were assessed for mechanical and transport properties (hy-
draulic permeability, k; equilibrium compressive Young’s
modulus, E-Y; and equilibrium tensile Young’s modulus, E+Y)
and subsequently evaluated for sGAG and collagen contents,
as well as their cellularities (DNA contents).
Materials
Bovine wrists were obtained from Green Village Packing
Co. (Green Village, NJ). High-glucose Dulbecco’s Modified
Eagle Medium (DMEM), glucose-free DMEM, penicillin,
streptomycin, amphotericin B (PS/AM) antibiotic–antimycotic,
fetal bovine serum (FBS), and PicoGreen dsDNA quan-
titation assay kit were purchased from Life Technologies
(Grand Island, NY). d-glucose, l-proline, agarose type VII-A,
ascorbic acid 2-phosphate (AAP), human recombinant in-
sulin, phosphate-buffered saline, dexamethasone, sodium
pyruvate, Tris–HCl, Trizma base, EDTA, diethylpyrocarbonate,
collagenase, and sodium selenite were obtained from Sigma-
Aldrich Corp. (St. Louis, MO). Human recombinant TGF-b3
was obtained from R&D Systems (Minneapolis, MN). ITS+
Premix, human holo transferrin, and bovine serum albumin/
linoleic acid complex were obtained from BD Biosciences (San
Jose, CA). Proteinase K was obtained from MP Biomedicals,
LLC (Solon, OH); 12 N HCl, iodoacetamide, and pepstatin A
were obtained from Fisher Scientific (Pittsburgh, PA).
Cell harvest and culture
Bovine articular cartilage was harvested from 2-month-old
calf carpometacarpal joints (n = 18, male and female). The
cartilage fragments were digested in high-glucose DMEM
supplemented with 5% FBS and collagenase for 6 h at 37C to
release chondrocytes, and then passed through a 70-mm
mesh to remove the debris. The freshly isolated chondrocytes
were suspended in the CM at 60· 106 cells/mL and mixed
with equal parts 4% (w/v) low-gelling-temperature agarose
in phosphate-buffered saline to yield a final concentration of
30 · 106 cells/mL in 2% agarose. The solution was poured
between glass slides and allowed 15 min to set, and a biopsy
punch was employed to form cylindrical constructs
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(ø4 · 2.34 mm). Constructs were cultured at 37C, 5% CO2 in
various media for 42 days; the media were changed three
times weekly.
Medium compositions
All media were based upon the standard CM: high-
glucose DMEM containing 100 nM dexamethasone, 100 mg/
mL sodium pyruvate, 50 mg/mL l-proline, 1% ITS + Premix
(final medium concentrations: 6.25 mg/mL human recombi-
nant insulin, 6.25 ng/mL selenous acid, 6.25 mg/mL human
holotransferrin, 1.25 mg/mL bovine serum albumin, and
5.35 mg/mL linoleic acid), 1% PS/AM antibiotic–antimycotic,
and 173 mM AAP. The concentrations of the five investigated
CM constituents were individually varied relative to the
1· standard: insulin (INS; 0· , 0.3· , 3· , 10· , and 30· ),
transferrin (TR; 0· , 0.3· , 3· , 10· , and 30· ), selenous acid
(SA; 0· , 0.1· , and 10· ), AAP (0· , 0.3· , 3· , 10· , and 30· ),
and glucose (GLU; 0· , 0.3· , and 3· ). AAP groups and their
1· control were prepared from the standard CM containing
1% ITS + Premix. For GLU groups and their 1· control,
glucose was added to the standard CM that had instead been
prepared with glucose-free DMEM. INS, TR, and SA groups
shared a 1· ITS control prepared using the individual con-
stituents of the ITS + Premix at their standard concentrations.
All media were supplemented with 10 ng/mL TGF-b3 for the
first 2 weeks of culture.2 The samples were taken from all
groups at days 0, 21, and 42 (n = 5 per group).
Mechanical characterization
Constructs were tested under unconfined compression
between impermeable platens in a CM bath. For each sam-
ple, a creep tare load of 0.005 N was first applied for 200 s,
and subsequently a stress-relaxation test was conducted that
comprised of a ramp displacement to 10% strain over 300 s
and then held until equilibrium was reached (*1800 s).
Stress-relaxation data were curve-fitted as previously de-
scribed.42 Briefly, finite element models were constructed
(FEBio43) that incorporated the geometry of the specimens,
and the engineered cartilage was modeled as a biphasic
material containing intrinsically incompressible fluid and
solid phases44; the composite porous solid phase consisted of
a compressible neo-Hookean solid ground matrix45 re-
inforced by a continuous, random distribution of fibril bun-
dles sustaining tension only, with a linear stress–strain
response; the hydraulic permeability was assumed con-
stant.42,46 A least-square parameter optimization routine in
FEBio43 was used to curve-fit the stress-relaxation data and
extract the specimen k, E-Y, and n (fibril tensile modulus)
values. These values were substituted into a finite element
analysis of equilibrium uniaxial tension to produce E+Y.
Biochemical characterization
Mechanically tested samples were lyophilized and di-
gested in proteinase K solution (0.5 mg/mL proteinase K,
50 mM Tris-buffered saline with 1 mM EDTA, 1 mM iodoa-
cetamide, and 10mg/mL pepstatin A) overnight at 56C.47,48
sGAG content was determined by 1,9-dimethylmethylene
blue dye-binding assay.49 PicoGreen dsDNA quantitation
assay was used to determine the DNA content.50 Collagen
content was assessed by assaying orthohydroxyproline
(OHP) as previously described47; briefly, proteinase K di-
gests were mixed with equal parts 12 N HCl and hydrolyzed
at 110C for 16 h, then dried, and resuspended in an OHP
assay buffer. The OHP content of the hydrolysis product was
assessed via chloramine T and dimethylaminobenzaldehyde
assay and a 1:7.64 OHP-to-collagen mass ratio was as-
sumed48; in similar chondrocyte–agarose constructs, it has
been shown that collagen measured by this method is pre-
dominantly type II.51 Contents of collagen and sGAG were
normalized to sample wet weights (%/ww), while DNA
contents were expressed in total mass per construct.
Statistics
Statistical significance was assessed using one-way AN-
OVA with Tukey’s HSD post hoc tests, with a= 0.05. E-Y, E+Y,
n, k, sGAG, collagen, and DNA content served as dependent
variables, while culture time or medium treatment served as
the independent variable. Data are reported as mean – stan-
dard deviation (n = 5).
Results
Mechanical characterization
Curve fits were generally faithful to the experimental data
(Fig. 1), producing near-unity coefficients of determination
(R2 = 0.968– 0.050, Table 1). After 42 days in culture, the
1· ITS control exhibited k= 2.3– 0.8· 10-3 mm4/N$s, E-Y=
518– 78 kPa, and E+Y= 1420– 430 kPa; statistically on par with
the 1· AAP control values (k= 5.4– 7.0· 10- 3 mm4/N$s,
E-Y= 401– 113 kPa, E+Y= 1140– 500 kPa). The 1· GLU con-
trol had k= 3.3– 1.7· 10- 3 mm4/N$s, E-Y= 236– 67 kPa, and
E+Y= 1240– 280 kPa. Complete removal of insulin or ascorbate
or reduction of glucose resulted in significantly higher k (Table
1) and significantly reduced E-Y (Fig. 2) and E+Y (Table 1) as
compared to their respective controls ( p< 0.005); in fact, 0·
INS, 0· AAP, 0· GLU, and 0.3· GLU possessed mechanical
properties similar to day-0 values (k *0.10 mm4/N$s, E-Y
*9 kPa, E+Y *80 kPa). The high doses 30· INS and 30· AAP
also exhibited significantly lower E-Y than controls ( p< 0.005),
FIG. 1. Representative curve fits for constructs with high
E-Y (1· ITS) and with low E-Y (30· AAP) during stress-
relaxation test of ramp to 10% strain, followed by 1500-s
relaxation. ITS, insulin-transferrin-selenium; AAP, ascorbic
acid 2-phosphate.
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and 30· INS yielded lower E+Y ( p< 0.05). Conversely, mod-
ulations in TR or SA dosages had no significant effect on E-Y
or E+Y ( p> 0.07), and only 0.3· TR exhibited a heightened k
( p< 0.05). Similar day-42 trends were observed at day 21, with
the exception of several TR and SA groups that showed re-
duced E-Y versus 1· control ( p< 0.05, data not shown).
Sulfated GAG content
sGAG contents ultimately reached 7.78 – 0.26 and
6.28 – 0.44%/ww in 1· ITS and 1· AAP controls, respec-
tively (Fig. 3). Within the treatment groups of ITS and AAP,
only 3· AAP exhibited a significantly elevated sGAG con-
tent of 9.54 – 1.60%/ww versus control ( p< 0.05). Subtraction
of insulin or ascorbate yielded dramatically reduced sGAG
contents ( p< 0.0005), 4-fold in the absence of ascorbate and
20-fold in that of insulin. Elaboration of sGAG appeared to
be insensitive to the changes in concentrations of transferrin
( p= 0.25) or selenous acid ( p= 0.56), as well as to nonzero
variations of insulin ( p> 0.5). The 1· GLU control’s content
reached 4.07 – 0.49%/ww; groups 0· GLU and 0.3· GLU
were significantly lower ( p< 0.0005), and 3· GLU was sig-
nificantly higher ( p< 0.01). Data from the day-21 timepoint
revealed the same trends, with the exception of the 3· AAP
group, which had not yet significantly exceeded its 1· con-
trol ( p= 0.22).
Collagen content
Collagen levels reached 1.27%– 0.22%, 1.06% – 0.33%, and
1.40% – 0.39% by wet weight in the 1· ITS control, 1· AAP
control, and 1· GLU control, respectively (Fig. 4). Significant
decreases in the collagen content were elicited by complete
removal of insulin, ascorbate, or glucose ( p < 0.0005), or in
Table 1. Hydraulic Permeabilities (k), Fibril Tensile Moduli (x), Equilibrium Tensile Young’s
Moduli (E+Y), and Coefficients of Determination of Curve Fits (R
2) of Day-42 Constructs
k (10 - 3 mm4/N$s) p n (kPa) p E+Y (kPa) p R
2
0· INS 60 – 13 < 0.0005 17 – 5 NS 170 – 40 < 0.05 0.978 – 0.011
30· INS 5.2 – 2.7 NS 24 – 13 NS 590 – 210 < 0.05 0.975 – 0.010
Other INS 3.1 – 1.5 — 53 – 31 — 1250 – 500 — 0.982 – 0.016
0.3· TR 4.7 – 1.5 < 0.05 38 – 13 NS 980 – 190 NS 0.990 – 0.003
Other TR 2.3 – 0.8 — 66 – 30 — 1530 – 500 — 0.990 – 0.06
All SA 2.7 – 1.0 — 52 – 24 — 1280 – 430 — 0.983 – 0.010
0· AAP 36.7 – 22.8 < 0.001 12 – 6 NS 150 – 50 < 0.01 0.897 – 0.077
Other AAP 4.0 – 4.3 — 50 – 20 — 1160 – 350 — 0.982 – 0.016
0· GLU 80.0 – 21.5 < 0.0005 12 – 10 < 0.0005 130 – 90 < 0.0005 0.827 – 0.111
0.3· GLU 40.7 – 11.4 < 0.005 15 – 7 < 0.0005 170 – 60 < 0.0005 0.843 – 0.135
1· GLU 3.3 – 1.3 — 70 – 18 — 1240 – 280 — 0.981 – 0.008
3· GLU 3.4 – 1.7 NS 41 – 9 < 0.05 920 – 170 NS 0.981 – 0.011
Statistically indistinct groups for each nutrient treatment have been condensed; p-values indicate statistical significance versus
corresponding 1· control or condensed group.
NS, no significance; INS, insulin; TR, transferrin; SA, selenous acid; AAP, ascorbic acid phosphate; GLU, glucose.
FIG. 2. Compressive Young’s moduli (E-Y) of constructs at
day 42. Asterisks (*) denote p < 0.05 versus corresponding
1· control; daggers ({) denote p< 0.05 versus corresponding
0· group; hash marks (#) denote other statistical differences
( p< 0.05). INS, insulin; TR, transferrin; SA, selenous acid;
GLU, glucose.
FIG. 3. sGAG contents of constructs at day 42. Asterisks (*)
denote p < 0.05 versus corresponding 1· control; daggers ({)
denote p < 0.05 versus corresponding 0· group; hash marks
(#) denote other statistical differences ( p < 0.05). sGAG, sul-
fated glycosaminoglycan.
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the case of reduced glucose (0.3· GLU, p< 0.0005). In all of
these groups, the measured collagen contents were extremely
low (< 0.2%/ww). Similar behavior was observed in day-21
collagen contents that became more pronounced over time
(data not shown). At this earlier time, the absence of selenous
acid appeared to have detrimental effects on collagen pro-
duction versus 1· control ( p< 0.005), but by the end of the
study, the concentrations of selenous acid and transferrin had
no effect on collagen ( p = 0.26 and p= 0.085, respectively).
DNA content
After 42 days in culture, DNA content in all the INS, TR,
SA, and AAP groups had increased roughly 4-fold from day-
0 levels (2.90 – 0.34 mg/disk for the INS, TR, SA, and AAP
groups; 4.85 – 0.35 mg/disk for GLU groups), except the GLU
groups and those lacking ascorbate or insulin. The control
DNA contents were 12.06– 0.56 and 11.53– 2.22 mg/disk for
1· AAP and 1· ITS controls, respectively (Fig. 5); both 0·
INS and 0· AAP were significantly lower ( p< 0.005). The 1·
GLU control ultimately reached 5.19 – 2.77 mg/disk. ANOVA
detected a significant influence of the glucose concentration
on DNA content at day 42 ( p = 0.03), though the Tukey’s
HSD post hoc analysis did not detect these specific differ-
ences. The overall DNA trends confirmed the results at day
21, though at that earlier time, the lower DNA contents in
groups 0· INS and 0· AAP were not yet appreciable, and
the 30· AAP group had temporarily exceeded the 1· AAP
control by threefold ( p < 0.005, data not shown).
Discussion
At the conclusion of the 6-week culture period, ITS and
AAP controls possessed compressive Young’s moduli ap-
proximately equal to the native values from similar bovine
sources (*550 kPa)52 and sGAG contents on par with that of
native cartilage (*4%/ww)53; the GLU control exhibited
native values of sGAG and *1/2 of native E-Y. Native levels
of type II collagen (*10%/ww),53 k (*5 · 10 - 4 mm4/N$s),52
and E+Y (*15–20 · 103 kPa)46,54 were not reached by any
groups. The absence of insulin, glucose, or ascorbate in the
culture medium corresponded to the lack of mechanical
stiffening and accretion of the matrix products within the
constructs (Figs. 2–4 and Table 1). Considering the roles of
glucose (anaerobic ATP production), insulin (cellular uptake
of glucose), and ascorbate (collagen synthesis), it is not sur-
prising to see the resulting poor functional properties.
However, such a dramatic a drop across the board in the
mechanical and biochemical properties places a strong em-
phasis upon the importance of transport and distribution of
insulin, glucose, and ascorbate within the construct. These
data suggest that it is vital to maintain sufficient concentra-
tions of these nutrients throughout the tissue volume if there
is to be matrix production at the center as well as the pe-
riphery.
While engineered cartilage constructs of the type and size
implemented in this study typically produce a more-
homogenous matrix,3,7,9 large heterogeneities of the elabo-
rated matrix are often observed in cultures of larger con-
structs.7,8 The observations in the current study give rise to
consideration as to whether deficiencies of these critical nu-
trients could be responsible for this behavior. Based upon the
lack of significant differences between 0.3· and controls for
insulin and ascorbate (Figs. 2–5 and Table 1), it is possible
that dose dependencies could exist at lower concentrations
than those implemented herein, and that elucidating these
dose dependencies could merit further study. When glucose
was reduced to 0.3· of the 25 mM concentration present in
high-glucose DMEM—slightly higher than the standard
glucose supplementation of 5.52 mM—dramatic reductions
in tissue mechanical integrity (Fig. 2 and Table 1) and matrix
deposition (Figs. 3 and 4) were observed. This reinforces the
utilization of a high-glucose medium in place of standard
DMEM in cartilage tissue engineering studies, and also
suggests that diminishing glucose concentrations within
constructs may impair tissue growth.
The media used during the culture phase of this study
were based upon a CM formulation, including ITS, as a
substitute for serum. It should be noted that although an
FIG. 4. Collagen contents of constructs at day 42. Asterisks
(*) denote p< 0.05 versus corresponding 1· control; daggers
({) denote p< 0.05 versus corresponding 0· group; hash marks
(#) denote other statistical differences ( p< 0.05).
FIG. 5. DNA contents of constructs at day 42. Asterisks (*)
denote p< 0.05 versus corresponding 1· control; daggers ({)
denote p< 0.05 versus corresponding 0· group; hash marks
(#) denote other statistical differences ( p < 0.05).
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FBS-containing medium formulation was used during the
24-h cartilage digestion step of the cell isolation procedure, it
is unlikely that this initial exposure to serum before construct
casting could have confounded the results of the study. The
ITS medium contains what are believed to be essential
supplements for proliferation of many cell types in a long-
term culture.31 While our results corroborate the impor-
tance of insulin in culture, no detrimental effects were
observed after 42 days in the absence of either transferrin or
selenous acid (Figs. 2–5 and Table 1). This would suggest
that the role of transferrin is not vital for chondrocyte sur-
vival or matrix synthesis, and perhaps that uptake of non-
transferrin-bound iron, which has been observed in various
other cell types,55,56 also occurs in chondrocytes. Similarly,
selenous acid was found to be unnecessary for developing
constructs, suggesting that either oxidative stress is not a
threat in this culture system, or the cells are able to com-
pensate for it. Further, cytotoxic effects that have previously
resulted from exposure to high selenium concentrations31
were not observed. These results are valuable for resolving
transport limitations in cartilage tissue engineering sys-
tems, as they suggest that concentrations of neither trans-
ferrin nor selenous acid need be considered as a limiting
factor in tissue growth. Although their absence does not
seem to elicit detrimental effects by day 42, it would be
prudent to continue the usage of both these constituents in
future studies, since day-21 results show some delays in
matrix elaboration in the absence of these constituents.
The glucose groups, which along with their control were
cast separately from ITS and ascorbate treatment groups,
exhibited lower E-Y (Fig. 2), sGAG contents (Fig. 3), and
DNA contents (Fig. 5) than the ITS and ascorbate groups.
While the cause of these differences is not entirely clear, it is
likely the result of variability intrinsic to the harvest and
casting processes. We have observed that constructs from
different casts may develop disparate properties, such as E-Y
and DNA, despite sharing similar casting conditions. Be-
cause the aim of this study was to modulate each constituent
separately, comparisons were only made relative to the
corresponding control for any given group.
While modulating glucose concentration affects the me-
dium osmolarity, and osmotic environment changes have
been shown to have an impact on chondrocyte metabo-
lism,57,58 the osmolarity change elicited in this study by re-
ducing glucose was low compared to osmolarities previously
studied, and therefore the resulting changes in tissue prop-
erties are likely attributed to the concentration of glucose.
Due to their lower medium concentrations, altering the con-
centrations of insulin, transferrin, selenous acid, or ascorbate
does not elicit substantial changes in the medium osmolarity.
The chondrocytes used were isolated from bovine calf
cartilage. Due to their availability for harvesting in large
numbers and their ability to readily produce the cartilage
matrix, these cells constitute an ideal model system and are
most practical for large-scale studies such as this (*250
constructs). For clinical tissue engineering applications
where the cell source may be diseased adult human chon-
drocytes or stem cells, it may be necessary to verify whether
the influences of the critical nutrients persist at similar con-
centrations. For example, diseased cells may exhibit lower
metabolic requirements, while the converse may be true for
stem cells.
With the exception of the highest dosage of selenium
(10· ), no treatments were found to increase the DNA content
of the constructs; lack of insulin or ascorbate yielded signifi-
cantly less DNA. Although it was not corroborated by
post hoc analysis, a significant effect of glucose concentration
on DNA was revealed by ANOVA, and therefore glucose
levels should be a consideration in related studies in which a
specific level of cell proliferation is desired. All other groups
increased similarly throughout the culture duration, sug-
gesting that the proliferation of chondrocytes within this
culture system is nearly independent from concentration
variations of ITS and ascorbate, so long as the insulin and
ascorbate levels remain above 0.3· . It should be noted that
while the DNA assay provides an estimate of the total cell
number, it does not examine the state of the cells. For the
purposes of this study, in which the most desired attributes of
the constructs were their mechanical properties and matrix
compositions, this simple estimate of the cell number was
employed. Further experiments would be required to char-
acterize specific cellular behavior such as cell fate processes.
The findings of this study have allowed us to identify
several nutrients in the CM that could potentially be limiting
for the growth of engineered cartilage: The presence of in-
sulin and ascorbate is essential, but their concentrations may
drop as low as 0.3·without detrimental effects; in contrast,
excessive supplementation of insulin or ascorbate can be
detrimental. The matrix elaboration was significantly de-
pendent on glucose concentration, with loss of functional
properties observed at 0.3· or less; however, excessive glu-
cose supplementation (up to 3· ) shows no detrimental ef-
fects. In contrast, transferrin and selenous acid appear to
have no long-term influence on matrix elaboration in this
culture system. Future work can now focus on transport and
consumption of these critical nutrients within constructs and
to what extent their availabilities influence construct inho-
mogeneity, especially as the construct dimensions increase.
This information will in turn help to strengthen the finite
element model predictions of transport and tissue growth, an
invaluable tool in developing strategies for growing cartilage
constructs of clinically relevant size.
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